Nocopi Reports 2020 Revenue of $2.7M, Operating Cash Flow of $0.7M, Net Income of $0.5M, or $0.01 per share, and Year-End Cash Position of $1.4M
Nocopi Technologies (OTC Pink: NNUP) reported its 2020 financial results, showing a 5% increase in revenue to $2.7M amid COVID-19 challenges. Cash flow from operations surged 95% to $702,400, and cash position improved to $1.4M. Despite a 22% drop in Q4 revenue due to lower product sales, net income for the year declined to $508,000 from $754,900, primarily due to rising costs. The company remains optimistic about future growth as economies reopen and consumer trends normalize, expecting benefits from international expansion and recovery in sales channels.
- Revenue increased by 5% to $2.7M in 2020.
- Cash flow from operations rose 95% to $702,400.
- Cash position improved to $1.4M at year-end 2020.
- Working capital grew to $2.8M, a 52% increase year-over-year.
- The company ended the year with no long-term debt.
- Q4 2020 revenue fell by 22%, with a 41% decrease in product sales.
- Net income for 2020 declined to $508,000 from $754,900 due to a 34% rise in cost of goods sold.
- Royalty revenue decreased by approximately $200,000 due to lower guaranteed licensing revenue.
KING OF PRUSSIA, Pa., March 30, 2021 (GLOBE NEWSWIRE) -- Nocopi Technologies, Inc. (OTC Pink: NNUP), a developer of specialty reactive inks used in entertainment, toy and educational products as well as in document and product authentication technologies to combat fraud, today announced results for its fourth quarter and year ended December 31, 2020 (Q4 ’20 and FY 2020). Nocopi’s SEC filings are available here.
2020 Highlights
- 2020 revenue rose
5% to$2.7M amidst COVID-19 pandemic, compared to$2.5M in 2019 - Cash flow from operations increased
95% to$702,400 in 2020 from$360,600 in 2019, driven by increased receivables collections - Cash increased to
$1.4M at year-end 2020, compared to$0.7M at year-end 2019 - Working capital increased to
$2.8M at year-end 2020 from$1.8M at year-end 2019 - Book value increased to
$3.5M at year-end 2020 compared to$2.8M at year-end 2019 - Extinguished a
$97,700 principal balance of convertible debt plus accrued interest of$46,100
Nocopi Chairman and CEO Michael Feinstein, M.D., commented, “Despite the challenges posed by COVID-19, Nocopi delivered a solid 2020 performance, with modest top-line growth, strong cash flow, profitability and meaningful improvements to our balance sheet and cash position. In particular, the COVID-19 pandemic negatively impacted consumer traffic at brick & mortar retailers, an important sales channel for consumer products utilizing our specialty ink technologies. The pandemic also halted the release and promotion of many family and kids-oriented feature films and entertainment franchises, limiting the visibility and demand for kids products based on these brands. While online channels helped to replace traditional retail sales, our partners experienced decreased product sell-through on which our royalty fees are based.
“During the year, Nocopi stayed focused on what we are able to control, including ongoing new ink technology R&D and new product initiatives in collaboration with our partners, along with a continued focus on expense management. Unfortunately, the pandemic did create some price volatility in certain commodities we use in our ink formulations which impacted gross margin for several months but has since returned to normalized trends.
"Looking forward we believe Nocopi is well positioned to benefit from the reopening economies and the gradual return to more normal business and consumer trends. We also expect to benefit from our partners' planned international expansion plans in Europe and other geographies that were originally slated for 2020 but were delayed by the pandemic. The return of consumer travel and retail foot traffic, combined with the return of entertainment brand launches, are expected to advance sales in the right direction going forward and are key to our optimistic outlook.
“Importantly, Nocopi’s cash collections were strong during 2020, as we ended the year with working capital of
FY 2020 Results
In 2020, Nocopi grew revenue by
License and royalty revenue in 2020 compared to 2019 decreased by approximately
Sales of ink to licensed printers of Nocopi licensees in the entertainment and toy products market were approximately
Nocopi’s net income for the year declined to
Cash flow from operations increased
During the third quarter of 2020, holders of all Nocopi's outstanding convertible debentures due in July elected to convert the
Q4 ‘20 Results
Q4 ’20 revenues decreased
Gross profit decreased to
Q4’20 operating expenses increased to
Principally reflecting lower gross profit, Nocopi’s net income declined to
CEO Feinstein concluded, “We expect the decline in specialty ink sales in the fourth quarter to be a temporary phenomenon as certain customers work through their existing production backlogs. We are already seeing an improving product sales trend in the current March quarter as one key customer has more than doubled their amount of ink orders placed relative to the same period last year. Our outlook is further reinforced by dialogues with partners and suppliers.”
About Nocopi Technologies (www.nocopi.com)
Nocopi develops and markets specialty reactive inks for unique, mess-free applications in the entertainment, toy and educational product markets. Nocopi also develops and markets document and product authentication technologies designed to combat fraudulent document reproduction, product counterfeiting and/or unauthorized product diversion. Nocopi derives revenue from technology licensing agreements as well as from the sale of its proprietary inks and other products to licensees and/or their licensed printers. Nocopi’s products and systems include trade secrets as well as patented technologies.
Safe Harbor for Forward-Looking Statements
This release may contain projections and other "forward-looking statements" relating to Nocopi’s business, that are often identified by the use of "believes," "expects" or similar expressions. Forward-looking statements involve a number of estimates, assumptions, risks and uncertainties that may cause actual results to differ materially from those anticipated. Forward-looking statements may address uncertainties regarding customer preferences or demand for products incorporating Nocopi technology that underlie the company’s revenue expectations, the company’s ability to develop new products and new product applications, the financial condition of customers and the timeliness of their payments, the impact of fluctuations in currencies, global trade and shipping markets, etc. Actual results could differ from those projected due to numerous factors and uncertainties, and Nocopi can give no assurance that such statements will prove to be correct nor that Nocopi’s actual results of operations, financial condition and performance will not differ materially from those reflected or implied by its forward-looking statements. Investors should refer to the risk factors outlined in Nocopi’s Form 10-K, 10-Q and other SEC reports available at www.sec.gov/edgar. Forward-looking statements are made as of the date of this news release; Nocopi assumes no obligation to update these statements.
Twitter – Investors: @NNUP_IR
Investor & Media Contacts
Chris Eddy or David Collins
Catalyst IR
212-924-9800 or nnup@catalyst-ir.com
Nocopi Technologies, Inc. Balance Sheets | ||||||||
December 31 | ||||||||
2020 | 2019 | |||||||
Assets | ||||||||
Current assets | ||||||||
Cash | $ | 1,362,800 | $ | 688,000 | ||||
Accounts receivable less | 1,280,800 | 1,352,300 | ||||||
Inventory | 324,800 | 127,900 | ||||||
Prepaid and other | 97,800 | 135,000 | ||||||
Total current assets | 3,066,200 | 2,303,200 | ||||||
Fixed assets | ||||||||
Leasehold improvements | 27,800 | 24,200 | ||||||
Furniture, fixtures and equipment | 163,700 | 252,500 | ||||||
191,500 | 276,700 | |||||||
Less: accumulated depreciation and amortization | 104,300 | 206,600 | ||||||
87,200 | 70,100 | |||||||
Other assets | ||||||||
Long-term receivables | 559,500 | 957,000 | ||||||
Operating lease right of use - building | 160,300 | 202,000 | ||||||
719,800 | 1,159,000 | |||||||
Total assets | $ | 3,873,200 | $ | 3,532,300 | ||||
Liabilities and Stockholders’ Equity | ||||||||
Current liabilities | ||||||||
Convertible debentures | $ | – | $ | 97,900 | ||||
Accounts payable | 5,700 | 44,300 | ||||||
Accrued expenses | 178,600 | 231,600 | ||||||
Income taxes | 36,300 | 52,400 | ||||||
Operating lease liability – current | 44,500 | 41,700 | ||||||
Total current liabilities | 265,100 | 467,900 | ||||||
Other liabilities | ||||||||
Accrued expenses, non-current | 39,200 | 67,000 | ||||||
Deferred income taxes | – | 47,400 | ||||||
Operating lease liability – non-current | 115,800 | 160,300 | ||||||
155,000 | 274,700 | |||||||
Commitments and contingencies | ||||||||
Stockholders’ equity | ||||||||
Series A preferred stock, | ||||||||
Authorized – 300,000 shares | ||||||||
Issued and outstanding – none | – | – | ||||||
Common stock, | ||||||||
Authorized – 75,000,000 shares | ||||||||
Issued and outstanding – 2020 - 67,353,690 shares; 2019 - 61,044,698 shares | 673,500 | 610,400 | ||||||
Paid-in capital | 12,575,800 | 12,483,900 | ||||||
Accumulated deficit | (9,796,200 | ) | (10,304,600 | ) | ||||
3,453,100 | 2,789,700 | |||||||
Total liabilities and stockholders’ equity | $ | 3,873,200 | $ | 3,532,300 | ||||
Statements of Comprehensive Income | ||||||||||||||||
Quarter ended December 31 | Year ended December 31 | |||||||||||||||
2020 | 2019 | 2020 | 2019 | |||||||||||||
Revenues | ||||||||||||||||
Licenses, royalties and fees | $ | 319,000 | $ | 221,900 | $ | 744,000 | $ | 793,800 | ||||||||
Product and other sales | 437,300 | 752,500 | 1,914,700 | 1,743,600 | ||||||||||||
756,300 | 974,400 | 2,658,700 | 2,537,400 | |||||||||||||
Cost of revenues | ||||||||||||||||
Licenses, royalties and fees | 53,600 | 70,900 | 223,800 | 169,100 | ||||||||||||
Product and other sales | 183,700 | 292,300 | 899,900 | 672,600 | ||||||||||||
237,300 | 363,200 | 1,123,700 | 841,700 | |||||||||||||
Gross profit | 519,000 | 611,200 | 1,535,000 | 1,695,700 | ||||||||||||
Operating expenses | ||||||||||||||||
Research and development | 49,800 | 43,000 | 173,500 | 165,600 | ||||||||||||
Sales and marketing | 95,500 | 105,700 | 356,400 | 329,900 | ||||||||||||
General and administrative | 142,600 | 128,700 | 526,100 | 393,900 | ||||||||||||
287,900 | 277,400 | 1,056,000 | 889,400 | |||||||||||||
Net income from operations | 231,100 | 333,800 | 479,000 | 806,300 | ||||||||||||
Other income (expenses) | ||||||||||||||||
Interest income | 5,900 | 4,500 | 18,200 | 11,700 | ||||||||||||
Interest expense and bank charges | (1,000 | ) | (2,800 | ) | (6,900 | ) | (10,800 | ) | ||||||||
4,900 | 1,700 | 11,300 | 900 | |||||||||||||
Net income before income taxes | 236,000 | 335,500 | 490,300 | 807,200 | ||||||||||||
Income taxes | 14,100 | 21,700 | (18,100 | ) | 52,300 | |||||||||||
Net income | $ | 221,900 | $ | 313,800 | $ | 508,400 | $ | 754,900 | ||||||||
Net income per common share | ||||||||||||||||
Basic | $ | 0.00 | $ | 0.01 | $ | 0.01 | $ | 0.01 | ||||||||
Diluted | $ | 0.00 | $ | 0.01 | $ | 0.01 | $ | 0.01 | ||||||||
Weighted average common shares outstanding | ||||||||||||||||
Basic | 67,353,690 | 58,616,716 | 64,052,777 | 59,443,207 | ||||||||||||
Diluted | 67,478,044 | 59,012,626 | 64,172,276 | 59,836,570 | ||||||||||||
Statements of Cash Flows | ||||||||
Years ended December 31 | ||||||||
2020 | 2019 | |||||||
Operating Activities | ||||||||
Net income | $ | 508,400 | $ | 754,900 | ||||
Adjustments to reconcile net income to net cash provided by operating activities | ||||||||
Depreciation and amortization | 21,500 | 10,800 | ||||||
Bad debt expense | 7,000 | – | ||||||
Deferred income taxes | (47,400 | ) | (61,400 | ) | ||||
Other assets | 439,200 | 193,200 | ||||||
Other liabilities | (69,500 | ) | 174,300 | |||||
Common stock issued for services | – | 25,400 | ||||||
859,200 | 1,097,200 | |||||||
(Increase) decrease in assets | ||||||||
Accounts receivable | 64,500 | (773,300 | ) | |||||
Inventory | (196,900 | ) | 5,600 | |||||
Prepaid and other | 37,200 | (91,400 | ) | |||||
Increase (decrease) in liabilities | ||||||||
Accounts payable and accrued expenses | (45,500 | ) | 108,700 | |||||
Income taxes | (16,100 | ) | 13,800 | |||||
(156,800 | ) | (736,600 | ) | |||||
Net cash provided by operating activities | 702,400 | 360,600 | ||||||
Investing Activities | ||||||||
Additions to fixed assets | (38,600 | ) | (73,400 | ) | ||||
Net cash used in investing activities | (38,600 | ) | (73,400 | ) | ||||
Financing Activities | ||||||||
Exercise of warrants | 11,000 | – | ||||||
Net cash provided by financing activities | 11,000 | – | ||||||
Increase in cash | 674,800 | 287,200 | ||||||
Cash | ||||||||
Beginning of year | 688,000 | 400,800 | ||||||
End of year | $ | 1,362,800 | $ | 688,000 | ||||
Cash paid for taxes | $ | 45,500 | $ | 100,000 | ||||
FAQ
What were Nocopi Technologies' total revenues for 2020?
How did cash flow from operations change in 2020 for NNUP?
What impact did COVID-19 have on Nocopi's sales?
What is the current cash position of Nocopi Technologies?